glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Mesothelioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, R; Fukuoka, K; Gu, T; Nakano, T; Nishio, K; Ohashi, R; Shimizu, K; Tajima, K; Takahashi, F; Takahashi, K | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Mesothelioma
Article | Year |
---|---|
Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
Topics: Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoenzyme Techniques; Immunoprecipitation; In Vitro Techniques; Integrin alphaVbeta3; Mesothelioma; Oligopeptides; Osteopontin; Phosphorylation; Pleural Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2009 |